Centogene N.V. (CNTGF) - Total Liabilities
Based on the latest financial reports, Centogene N.V. (CNTGF) has total liabilities worth $102.44 Million USD as of December 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CNTGF long-term investment intensity to see how much of total assets are deployed in long-term investments.
Centogene N.V. - Total Liabilities Trend (2020–2023)
This chart illustrates how Centogene N.V.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Centogene N.V. assets under control.
Centogene N.V. Competitors by Total Liabilities
The table below lists competitors of Centogene N.V. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
VH Global Sustainable Energy Opportunities PLC
LSE:GSEO
|
UK | GBX349.00K |
|
C.I. Group Public Company Limited
BK:CIG
|
Thailand | ฿586.77 Million |
|
Property Franchise Group PLC
LSE:TPFG
|
UK | GBX51.32 Million |
|
ReTo Eco-Solutions Inc
NASDAQ:RETO
|
USA | $7.10 Million |
|
NextEnergy Solar Fund Ltd
LSE:NESF
|
UK | GBX201.29 Million |
|
AltynGold plc
LSE:ALTN
|
UK | GBX65.10 Million |
|
Omnia Metals Group Ltd
AU:OM1
|
Australia | AU$276.32K |
|
PROSPECT RIDGE RESOURCES
F:0ED
|
Germany | €445.65K |
Liability Composition Analysis (2020–2023)
This chart breaks down Centogene N.V.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Centogene N.V.'s balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -4.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Centogene N.V.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Centogene N.V. (2020–2023)
The table below shows the annual total liabilities of Centogene N.V. from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $102.44 Million | +19.95% |
| 2022-12-31 | $85.40 Million | +33.69% |
| 2021-12-31 | $63.88 Million | -24.84% |
| 2020-12-31 | $84.99 Million | -- |
About Centogene N.V.
Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA … Read more